PT010005-03

  • STATUS
    Recruiting
  • sponsor
    Pearl Therapeutics, Inc
Updated on 25 March 2021

Summary

PT010005-03

Description

A study to assess the efficacy and safety of PT010 relative to PT003 and PT009 on COPD exacerbations over a 52 week treatment period in subjects with moderate to very severe COPD. Phase III Patients will be randomized to a medication. There is not a placebo arm in this study. There is a subject payment stipend of $125 to offset their time and travel expense which is paid to the patient at each visit.

Details
Condition COPD (Chronic Obstructive Pulmonary Disease)
Clinical Study IdentifierTX148177
SponsorPearl Therapeutics, Inc
Last Modified on25 March 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Ability to read and sign a written consent form
A COPD diagnosis and a current or former smoker of at least 10 pack years
Currently using two or more inhaled maintenance therapies for the management of COPD for at least 6 weeks prior to Visit 1
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note